Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14896297 | 0.81 | DGAT1 (0.32) | — | |
| SCHEMBL26049353 | 0.78 | CYP1A2 (0.31) | — | |
| SCHEMBL27459045 | 0.74 | CHRM2 (0.43) | CHRM2CHRM1CHRM3 | |
| SCHEMBL26048597 | 0.73 | MEN1 (0.31) | — | |
| SCHEMBL26707334 | 0.73 | CHRM2 (0.30) | CHRM2CHRM1CHRM3 | |
| SCHEMBL6069327 | 0.72 | — | — | |
| SCHEMBL17799294 | 0.72 | — | — | |
| SCHEMBL25879979 | 0.72 | HPGD (0.31) | CHRM2CHRM1CHRM3 | |
| SCHEMBL15544491 | 0.71 | — | — | |
| SCHEMBL26048690 | 0.71 | CHRNB2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023244764-A1 | COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 | C4 THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| EP-3442977-B1 | INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE | BLUEPRINT MEDICINES CORP (US) | 2023-06-28 | — | — | EP | disclosed |
| EP-2251334-B1 | Labeling reagents and labeled analytes | DH TECHNOLOGIES DEV PTE LTD (SG) | 2013-08-14 | — | — | EP | disclosed |
| EP-2251334-A1 | Labeling reagents and labeled analytes | Life Technologies Corporation (US) | 2010-11-17 | — | — | EP | disclosed |